ECS Botanics HoldingsASX:ECS Days Payable is 60.64 as of Dec. 2025, which is 27% below its 10-year median of 82.54. The stock has 9 warning signs investors should review. Among 923 Drug Manufacturers companies, ECS Botanics Holdings ranks better than 63.6% on this metric.
ECS Botanics Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for ECS Botanics Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, ECS Botanics Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ECS Botanics Holdings Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ECS Botanics Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where ECS Botanics Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
ECS Botanics Holdings's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ECS Botanics Holdings (ASX:ECS) has a Days Payable of 60.64 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ECS Botanics Holdings and its competitors. This is 27% below median its historical median of 82.54. Over the past decade, ECS Botanics Holdings' Days Payable has ranged from 47.63 to 140.64. According to the industry distribution chart, ECS Botanics Holdings ranks #336 out of 923 companies in the Drug Manufacturers industry, placing it in the top 36.4%.
Is ECS Botanics Holdings' Days Payable too high?
ECS Botanics Holdings' current Days Payable of 60.64 is 27% below median its 10-year median of 82.54. Over the past 10 years, this metric has ranged from a low of 47.63 to a high of 140.64. The Drug Manufacturers industry median Days Payable is 90.98. ECS Botanics Holdings' value of 60.64 is 33.3% below this industry median. Based on the distribution chart, ECS Botanics Holdings ranks #336 out of 923 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does ECS Botanics Holdings' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, ECS Botanics Holdings ranks #336 out of 923 companies for Days Payable. This puts ECS Botanics Holdings in the upper half of its industry. The industry median Days Payable is 90.98. ECS Botanics Holdings' value of 60.64 is 33.3% below this benchmark. Historically, ECS Botanics Holdings' own Days Payable has ranged from 47.63 to 140.64 over the past decade. While the company's 10-year median is 82.54 vs. the industry median of 90.98, ECS Botanics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ECS Botanics Holdings's current Days Payable of 60.64 is 33.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ECS Botanics Holdings and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ECS Botanics Holdings's current Days Payable is 60.64, which is 27% below median its own 10-year median of 82.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ECS Botanics Holdings stock overvalued right now?
Based on GuruFocus' analysis, ECS Botanics Holdings (ASX:ECS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 80% below its estimated fair value. The current Days Payable is 60.64, which is 27% below median its 10-year median of 82.54 and 33.3% below the Drug Manufacturers industry median of 90.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For ECS Botanics Holdings (ASX:ECS), the current Days Payable is 60.64 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ECS Botanics Holdings Ltd is an Australian medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The company utilizes progressive cultivation methodologies to produce quality medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. Licensed by the Therapeutic Drug Administration to manufacture PIC/S GMP certified products, the company provides quality, affordable medicinal cannabis, supplying both local and overseas markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ECS has been successfully added to your 